Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hyperfine (HYPR) Other Accumulated Expenses (2020 - 2025)

Historic Other Accumulated Expenses for Hyperfine (HYPR) over the last 6 years, with Q3 2025 value amounting to $257000.0.

  • Hyperfine's Other Accumulated Expenses fell 6033.95% to $257000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $257000.0, marking a year-over-year decrease of 6033.95%. This contributed to the annual value of $473000.0 for FY2024, which is 605.38% up from last year.
  • As of Q3 2025, Hyperfine's Other Accumulated Expenses stood at $257000.0, which was down 6033.95% from $225000.0 recorded in Q2 2025.
  • In the past 5 years, Hyperfine's Other Accumulated Expenses registered a high of $648000.0 during Q3 2024, and its lowest value of $19000.0 during Q4 2021.
  • For the 5-year period, Hyperfine's Other Accumulated Expenses averaged around $246875.0, with its median value being $210000.0 (2022).
  • In the last 5 years, Hyperfine's Other Accumulated Expenses soared by 107368.42% in 2023 and then plummeted by 6033.95% in 2025.
  • Quarter analysis of 5 years shows Hyperfine's Other Accumulated Expenses stood at $19000.0 in 2021, then surged by 100.0% to $38000.0 in 2022, then soared by 1073.68% to $446000.0 in 2023, then rose by 6.05% to $473000.0 in 2024, then crashed by 45.67% to $257000.0 in 2025.
  • Its Other Accumulated Expenses stands at $257000.0 for Q3 2025, versus $225000.0 for Q2 2025 and $169000.0 for Q1 2025.